AngioDynamics Inc
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall … Read more
AngioDynamics Inc (ANGO) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of November 2025: 0.026x
Based on the latest financial reports, AngioDynamics Inc (ANGO) has a cash flow conversion efficiency ratio of 0.026x as of November 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($4.66 Million) by net assets ($176.33 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
AngioDynamics Inc - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how AngioDynamics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
AngioDynamics Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of AngioDynamics Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SanBio Company Limited
OTCGREY:SNBIF
|
-1.187x |
|
Hengxin Mobile Business
SHE:300081
|
-0.006x |
|
RWS Holdings plc
PINK:RWSPF
|
0.044x |
|
Hootech Inc.
SHE:301026
|
N/A |
|
Natural Grocers by Vitamin Cottage Inc
NYSE:NGVC
|
0.096x |
|
Tremor International Ltd
PINK:TTTPF
|
0.098x |
|
Intrum AB (publ)
PINK:ITJTY
|
0.155x |
|
Depo Auto Parts Industrial Co Ltd
TW:6605
|
0.053x |
Annual Cash Flow Conversion Efficiency for AngioDynamics Inc (2002–2025)
The table below shows the annual cash flow conversion efficiency of AngioDynamics Inc from 2002 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-05-31 | $182.97 Million | $-10.13 Million | -0.055x | +59.59% |
| 2024-05-31 | $205.59 Million | $-28.16 Million | -0.137x | -66527.12% |
| 2023-05-31 | $378.30 Million | $78.00K | 0.000x | +101.22% |
| 2022-05-31 | $424.49 Million | $-7.19 Million | -0.017x | -130.91% |
| 2021-05-31 | $439.46 Million | $24.09 Million | 0.055x | +271.73% |
| 2020-05-31 | $455.87 Million | $-14.55 Million | -0.032x | -152.43% |
| 2019-05-31 | $614.82 Million | $37.44 Million | 0.061x | -19.97% |
| 2018-05-31 | $542.60 Million | $41.29 Million | 0.076x | -29.43% |
| 2017-05-31 | $517.03 Million | $55.74 Million | 0.108x | +20.90% |
| 2016-05-31 | $507.03 Million | $45.22 Million | 0.089x | +89.23% |
| 2015-05-31 | $545.02 Million | $25.68 Million | 0.047x | +2.71% |
| 2014-05-31 | $537.89 Million | $24.68 Million | 0.046x | -9.30% |
| 2013-05-31 | $526.83 Million | $26.65 Million | 0.051x | +128.22% |
| 2012-05-31 | $523.39 Million | $11.60 Million | 0.022x | -73.44% |
| 2011-05-31 | $405.75 Million | $33.87 Million | 0.083x | -18.25% |
| 2010-05-31 | $391.35 Million | $39.96 Million | 0.102x | +90.57% |
| 2009-05-31 | $372.19 Million | $19.94 Million | 0.054x | -26.43% |
| 2008-05-31 | $355.71 Million | $25.91 Million | 0.073x | +178.55% |
| 2007-05-31 | $335.96 Million | $8.78 Million | 0.026x | +0.26% |
| 2006-05-31 | $123.44 Million | $3.22 Million | 0.026x | -73.25% |
| 2005-05-31 | $49.11 Million | $4.79 Million | 0.097x | +45.20% |
| 2004-05-31 | $37.23 Million | $2.50 Million | 0.067x | -85.31% |
| 2003-05-31 | $1.49 Million | $680.00K | 0.457x | +111.18% |
| 2002-05-31 | $-295.00K | $1.21 Million | -4.088x | -- |